Dynavax Technologies (LTS:0IDA) Scaled Net Operating Assets : 0.16 (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Dynavax Technologies Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Dynavax Technologies's operating assets for the quarter that ended in Sep. 2024 was $298.0 Mil. Dynavax Technologies's operating liabilities for the quarter that ended in Sep. 2024 was $130.4 Mil. Dynavax Technologies's Total Assets for the quarter that ended in Jun. 2024 was $1,016.3 Mil. Therefore, Dynavax Technologies's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.16.

Dynavax Technologies Scaled Net Operating Assets Historical Data

The historical data trend for Dynavax Technologies's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dynavax Technologies Scaled Net Operating Assets Chart

Dynavax Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.35

0.40

-0.19

0.21

0.14

Dynavax Technologies Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.15	0.14	0.15	0.16	0.17

Competitive Comparison of Dynavax Technologies's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Dynavax Technologies's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dynavax Technologies's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dynavax Technologies's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Dynavax Technologies's Scaled Net Operating Assets falls into.

Dynavax Technologies Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Dynavax Technologies's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(254.794	-	118.11)	/	985.85
=	0.14

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	997.096	-	742.302
=	254.794

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	375.024	-	252.418	-	4.496
=	118.11

Dynavax Technologies's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2024 )
=	(Operating Assets (Q: Sep. 2024 )	-	Operating Liabilities (Q: Sep. 2024 ))	/	Total Assets (Q: Jun. 2024 )
=	(297.998	-	130.395)	/	1016.321
=	0.16

where

	Operating Assets		(Q: Sep. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	1061.99	-	763.992
=	297.998

	Operating Liabilities		(Q: Sep. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	380.563	-	250.168	-	0
=	130.395

Dynavax Technologies Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Dynavax Technologies's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Dynavax Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dynavax Technologies Corp (LTS:0IDA) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

DVAX:USA DYF1:Germany DYF1:Germany

Address

2100 Powell Street, Suite 720, Emeryville, CA, USA, 94608

Website

https://www.dynavax.com

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Dynavax Technologies Headlines

No Headlines